Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.46 |
| ▸ | C5 | P01031 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174047 | 0.92 | PTGS2 (0.48) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6170333 | 0.80 | PTGS2 (0.59) | PTGS2PTGS1 | |
| SCHEMBL6171537 | 0.79 | PTGS2 (0.53) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6170764 | 0.79 | PTGS2 (0.46) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6168997 | 0.78 | PTGS2 (0.52) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6171539 | 0.78 | PTGS2 (0.45) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6172166 | 0.78 | PTGS2 (0.49) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6170629 | 0.77 | PTGS2 (0.49) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL6171988 | 0.77 | PTGS2 (0.46) | PTGS2MAPTMEN1ABCC4C5 | |
| SCHEMBL27574874 | 0.77 | MAPT (0.46) | MAPTPOLBLMNAGAAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045833-B1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER (US) | 2005-11-02 | — | — | EP | claimed |
| US-6608070-B1 | Useful for treatment of medical condition in which prostaglandins are implicated as pathogens | NAKAO KAZUNARI (JP) | 2003-08-19 | — | — | US | claimed |
| US-6608070-B1 | Useful for treatment of medical condition in which prostaglandins are implicated as pathogens | NAKAO KAZUNARI (JP) | 2003-08-19 | — | — | US | disclosed |